Back to top

Tale of the Tape

Zacks Equity Research

Will Eagle Pharmaceuticals (EGRX) Continue to Surge Higher?
November 04, 2016


Trades from $3

As of late, it has definitely been a great time to be an investor in Eagle Pharmaceuticals Inc. (EGRX - Free Report) . The stock has moved higher by 10.4% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could suggest that the stock may be on the right path.

We certainly think that this might be the case, particularly if you consider EGRX’s recent earnings estimate revision activity. From this look, the company’s future is quite favorable; as EGRX has earned itself a Zacks Rank #2 (Buy), meaning that its recent run may continue for a bit longer, and that this isn’t the top for the in-focus company. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Confidential from Zacks

Beyond this Tale of the Tape, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand.Click to see them now>>

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Eagle Pharmaceuticals, Inc. (EGRX) - free report >>